ursodeoxycholic acid has been researched along with Cardiomyopathies in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Aguirre, MA; Baratta, S; Belziti, CA; Carretero, M; Costabel, JP; Dumont, CA; Fernández, A; Higa, C; Negro, A; Nucifora, EM; Perez de Arenaza, D; Posadas-Martínez, ML; Quiroga, A; Rivas, C; Streitenberg, GM; Villanueva, E; Volberg, VI | 1 |
| Costelha, S; Martins, HS; Saraiva, MJ; Teixeira, A; Teixeira, C | 1 |
| Dixon, P; Ferraro, E; Gorelik, J; Ibrahim, E; Vasavan, T; Williamson, C | 1 |
| Baumann, U; Beerbaum, P; Hohmann, D; Junge, C; Junge, N; Leiskau, C; Pfister, ED; Schröder, J | 1 |
| Anan, I; Lundgren, HE; Olsson, M; Pilebro, B; Wixner, J | 1 |
| Battarbee, HD; Zavecz, JH | 1 |
1 review(s) available for ursodeoxycholic acid and Cardiomyopathies
| Article | Year |
|---|---|
Heart and bile acids - Clinical consequences of altered bile acid metabolism.
Topics: Apoptosis; Arrhythmias, Cardiac; Bile Acids and Salts; Cardiomyopathies; Cholagogues and Choleretics; Cholangitis; Cholestasis, Intrahepatic; Female; Heart; Hemodynamics; Humans; Hydrophobic and Hydrophilic Interactions; Liver Cirrhosis, Biliary; Maternal-Fetal Exchange; Myocytes, Cardiac; Pregnancy; Pregnancy Complications; Prevalence; Ursodeoxycholic Acid | 2018 |
1 trial(s) available for ursodeoxycholic acid and Cardiomyopathies
| Article | Year |
|---|---|
Effect of doxycycline and ursodeoxycholic acid on transthyretin amyloidosis.
Topics: Aged; Aged, 80 and over; Amyloid; Amyloid Neuropathies, Familial; Biomarkers; Cardiomyopathies; Doxycycline; Drug Administration Schedule; Drug Therapy, Combination; Female; Gene Expression; Humans; Male; Middle Aged; Mutation; Natriuretic Peptide, Brain; Patient Dropouts; Peptide Fragments; Prealbumin; Prospective Studies; Survival Analysis; Treatment Failure; Ursodeoxycholic Acid | 2017 |
4 other study(ies) available for ursodeoxycholic acid and Cardiomyopathies
| Article | Year |
|---|---|
[Specific pharmacological treatment guide for transthyretin amyloid cardiomyopathy, 2021].
Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Diflunisal; Doxycycline; Humans; Prealbumin; Ursodeoxycholic Acid | 2022 |
Doxycycline-tauroursodeoxycholic acid treatment: effects in the heart of a transthyretin V30M transgenic mouse model.
Topics: Amyloid; Amyloid Neuropathies, Familial; Animals; Biomarkers; Cardiomyopathies; Collagen Type IV; Disease Models, Animal; Doxycycline; Drug Administration Schedule; Drug Therapy, Combination; Gene Expression; Heart; Heat Shock Transcription Factors; Humans; Male; Mice; Mice, Transgenic; Mutation; Natriuretic Peptide, Brain; Peptide Fragments; Prealbumin; Ursodeoxycholic Acid | 2017 |
Pediatric cirrhotic cardiomyopathy: Impact on liver transplant outcomes.
Topics: Adolescent; Cardiomyopathies; Child; Child, Preschool; Cholagogues and Choleretics; Cholestasis; Echocardiography; Electrocardiography; End Stage Liver Disease; Female; Humans; Incidence; Infant; Length of Stay; Liver Cirrhosis; Liver Transplantation; Male; Retrospective Studies; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid | 2018 |
The role of lipophilic bile acids in the development of cirrhotic cardiomyopathy.
Topics: Animals; Bile Acids and Salts; Cardiomyopathies; Cholic Acid; Excitation Contraction Coupling; Liver Cirrhosis, Experimental; Male; Myocardial Contraction; Myocytes, Cardiac; Organ Culture Techniques; Papillary Muscles; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Signal Transduction; Ursodeoxycholic Acid | 2010 |